Read before the session on large scale antigen purification. Federation of American Societies for Experimental Biology, Atlantic City, NJ, April 17, 1968.
Reprint requests to Lilly Laboratory for Clinical Research, Marion County General Hospital, Indianapolis 46207.
The development of procedures for the use of the K-II continuous flow zonal ultracentrifuge has resulted, for the first time, in the availability of large quantities of highly purified influenza virus vaccine essentially free of nonviral egg-derived material. With these vaccines, it was determined that the inherent toxicity of purified virus strains and combinations thereof is uniformly low, and that the variable side effects frequently seen with conventionally produced vaccines are not virus related. Purified vaccines are equal in antigenicity to equivalent doses of conventional vaccines, demonstrating that nonviral components of conventional vaccine have no beneficial effects on vaccine antigenicity. Purified vaccine of twice normal potency is no more reactogenic than the same vaccine in standard doses, indicating that future vaccines of even higher potency and low reactivity are well within the realm of possibility.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.